Compugen Ltd. (CGEN)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
Sep 09, 16:00
2.48
0.00 (0.00%)
After-Hours: 19:05
Compugen EPS Diluted (Quarterly) : -0.074 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.074 |
| March 31, 2026 | -0.0811 |
| December 31, 2025 | 0.6002 |
| September 30, 2025 | -0.0746 |
| June 30, 2025 | -0.0785 |
| March 31, 2025 | -0.0778 |
| December 31, 2024 | -0.0683 |
| September 30, 2024 | 0.0142 |
| June 30, 2024 | -0.0237 |
| March 31, 2024 | -0.0812 |
| December 31, 2023 | 0.1099 |
| September 30, 2023 | -0.1116 |
| June 30, 2023 | -0.1064 |
| March 31, 2023 | -0.1078 |
| December 31, 2022 | -0.0357 |
| September 30, 2022 | -0.1356 |
| June 30, 2022 | -0.1057 |
| March 31, 2022 | -0.1123 |
| December 31, 2021 | -0.1013 |
| September 30, 2021 | -0.0733 |
| June 30, 2021 | -0.1133 |
| March 31, 2021 | -0.1184 |
| December 31, 2020 | -0.103 |
| September 30, 2020 | -0.0933 |
| June 30, 2020 | -0.0768 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1014 |
| December 31, 2019 | -0.0955 |
| September 30, 2019 | -0.0992 |
| June 30, 2019 | -0.0972 |
| March 31, 2019 | -0.1401 |
| December 31, 2018 | -0.1578 |
| September 30, 2018 | -0.0544 |
| June 30, 2018 | -0.1955 |
| March 31, 2018 | 0.002 |
| December 31, 2017 | -0.18 |
| September 30, 2017 | -0.19 |
| June 30, 2017 | -0.18 |
| March 31, 2017 | -0.17 |
| December 31, 2016 | -0.17 |
| September 30, 2016 | -0.15 |
| June 30, 2016 | -0.13 |
| March 31, 2016 | -0.17 |
| December 31, 2015 | -0.01 |
| September 30, 2015 | -0.13 |
| June 30, 2015 | -0.13 |
| March 31, 2015 | -0.12 |
| December 31, 2014 | -0.03 |
| September 30, 2014 | -0.11 |
| June 30, 2014 | -0.05 |
| March 31, 2014 | -0.04 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pluri, Inc. | -0.5518 |
| Evogene Ltd. | -0.1449 |
| Scinai Immunotherapeutics Ltd. | -3.662 |
| CollPlant Biotechnologies Ltd. | -0.2253 |
| Regentis Biomaterials Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.006M |
| Revenue (Quarterly) | 2.602M |
| Total Expenses (Quarterly) | 9.608M |
| Enterprise Value | 120.22M |
| Gross Profit Margin (Quarterly) | -3.54% |
| Profit Margin (Quarterly) | -269.3% |
| Earnings Yield | 14.94% |
| Operating Earnings Yield | 12.95% |
| Normalized Earnings Yield | 14.94 |